Last reviewed · How we verify
NCT06360055
Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults
NA trial testing Dabigatran Etexilate in Health in 12 participants. Currently enrolling.
30 November 2024
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 1 April 2024 |
| Primary completion | 30 November 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Dabigatran Etexilate (DABIGATRAN) — full drug profile →
- D-mannose — full drug profile →
Conditions studied
- Health — all drugs for Health →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 45, male only, with Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the effects of oral D-mannose tablets for 2 consecutive weeks on the pharmacokinetics of dabigatrun etexilate, a P-glycoprotein probe substrate drug, in healthy adults
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06360055
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dabigatran Etexilate
Trials testing the same drug.
- NCT07190430 — A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Calle · Phase 1 · active not recruiting
- NCT05735639 — THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) · Phase 4 · recruiting
- NCT05438303 — Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celec · Phase 1 · completed
- NCT05347979 — Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy · Phase 1 · completed
- NCT05368805 — Fruquintinib DDI Study With P-gp and BCRP Substrates · Phase 1 · completed
Other recruiting trials for Health
Currently open trials in the same condition.
- NCT07356492 — Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Me · NA · recruiting
- NCT06854536 — A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies · active not recruiting
- NCT06691100 — How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types · NA · recruiting
- NCT06157346 — Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude · recruiting
- NCT05701657 — Nutrition for Precision Health, Powered by the All of Us · NA · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06360055 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06360055.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing